文献速递糖尿病

乳糜泻与2型糖尿病风险:一项全国性匹配队列与孟德尔随机化研究

Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
PubMed 文献 · Diabetologia · 2024-05-21

该全国性匹配队列纳入瑞典ESPRESSO队列中46150例乳糜泻患者和219763名匹配对照,随访1969至2021年,并利用9053例二次活检者分析持续性绒毛萎缩与2型糖尿病的关系,同时进行孟德尔随机化分析。结果显示乳糜泻与2型糖尿病风险无关(HR 1.00,95%CI 0.97,1.03),持续性绒毛萎缩与黏膜愈合者相比2型糖尿病风险无增加(HR 1.02,95%CI 0.90,1.16),遗传易感性在DIAGRAM(OR 1.01,95%CI 0.99,1.03)和FinnGen(OR 1.01,95%CI 0.99,1.04)中均无关联。

要点

  • 乳糜泻患者与匹配对照的2型糖尿病发生风险无显著差异(HR 1.00,95%CI 0.97,1.03)。
  • 持续性绒毛萎缩与黏膜愈合相比,2型糖尿病风险无显著增加(HR 1.02,95%CI 0.90,1.16)。
  • 乳糜泻遗传易感性在DIAGRAM和FinnGen中均与2型糖尿病无显著关联。

核心结论

  • 乳糜泻与2型糖尿病风险无关。

研究设计与样本

  • 全国性匹配队列使用瑞典ESPRESSO队列数据,纳入46150例乳糜泻患者和219763名匹配对照,随访1969至2021年。
  • 另用9053例接受二次活检的乳糜泻患者数据分析持续性绒毛萎缩与2型糖尿病的关系。
  • 采用多变量Cox回归估计关联,并进行孟德尔随机化分析,使用37个与临床诊断乳糜泻相关的独立遗传变异(p<5×10-8)作为遗传易感性代理。
  • 2型糖尿病汇总数据来自DIAGRAM联盟(80154例病例)和FinnGen研究(42593例病例)。

主要发现

  • 中位随访15.7年期间,乳糜泻患者中2型糖尿病新发病例为6132例(13.3%),匹配对照中为30138例(13.7%)。
  • 乳糜泻患者与匹配对照相比,2型糖尿病发病风险无增加(HR 1.00,95%CI 0.97,1.03)。
  • 在乳糜泻患者中,持续性绒毛萎缩与黏膜愈合相比,2型糖尿病风险无增加(HR 1.02,95%CI 0.90,1.16)。
  • 乳糜泻遗传易感性与2型糖尿病在DIAGRAM中无关联(OR 1.01,95%CI 0.99,1.03),在FinnGen中亦无关联(OR 1.01,95%CI 0.99,1.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: While the association between coeliac disease and type 1 diabetes is well documented, the association of coeliac disease with type 2 diabetes risk remains undetermined. We conducted a nationwide cohort and Mendelian randomisation analysis to investigate this link. METHODS: This nationwide matched cohort used data from the Swedish ESPRESSO cohort including 46,150 individuals with coeliac disease and 219,763 matched individuals in the comparator group selected from the general population, followed up from 1969 to 2021. Data from 9053 individuals with coeliac disease who underwent a second biopsy were used to examine the association between persistent villous atrophy and type 2 diabetes. Multivariable Cox regression was employed to estimate the associations. In Mendelian randomisation analysis, 37 independent genetic variants associated with clinically diagnosed coeliac disease at p<5×10-8 were used to proxy genetic liability to coeliac disease. Summary-level data for type 2 diabetes were obtained from the DIAGRAM consortium (80,154 cases) and the FinnGen study (42,593 cases). RESULTS: Over a median 15.7 years' follow-up, there were 6132 (13.3%) and 30,138 (13.7%) incident cases of type 2 diabetes in people with coeliac disease and comparator individuals, respectively. Those with coeliac disease were not at increased risk of incident type 2 diabetes with an HR of 1.00 (95% CI 0.97, 1.03) compared with comparator individuals. Persistent villous atrophy was not associated with an increased risk of type 2 diabetes compared with mucosal healing among participants with coeliac disease (HR 1.02, 95% CI 0.90, 1.16). Genetic liability to coeliac disease was not associated with type 2 diabetes in DIAGRAM (OR 1.01, 95% CI 0.99, 1.03) or in FinnGen (OR 1.01, 95% CI 0.99-1.04). CONCLUSIONS/INTERPRETATION: Coeliac disease was not associated with type 2 diabetes risk.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Yuan S, Leffler D, Lebwohl B, et al. Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study. Diabetologia. 2024. PMID: 38772918. doi:10.1007/s00125-024-06175-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。